A groundbreaking cancer drug has been developed that targets and destroys solid tumours without harming healthy cells. The drug, code-named AOH1996, targets the protein proliferating cell nuclear antigen (PCNA), a key player in tumour growth previously considered “undruggable.” After two decades of research, scientists at City of Hope Hospital in Los Angeles, California, USA, successfully…